Cyclic Homooligomers from Sugar Amino Acids
Hz, 2H), 4.60 (d, J ) 6.5 Hz, 2H), 4.68 (d, J ) 11.4 Hz, 2H),
4.74 (d, J ) 6.5 Hz, 2H), 4.78 (d, J ) 11.4 Hz, 2H), 4.87 (d, J
) 6.8 Hz, 2H), 6.83-6.95 (m, 2H), 7.22-7.40 (m, 10H); 13C
NMR (62.9 MHz, CDCl3) δ 32.3, 40.4, 56.2, 56.6, 71.3, 72.2,
75.3, 77.2, 77.3, 80.0, 97.7, 98.2, 127.9, 128.6, 138.1, 170.2. MS
(MALDI): m/z 785.6 [M + Na]+.
Synthesis of Cyclic Dimer 15. Compound 1 (50 mg, 0.066
mmol) was debenzylated with Pd/C and Pd black (1:1, 20%
w/w) in a MeOH/EtOAc/AcOH (1:1:0.4, 2.4 mL) mixture
according to general method F and purified over silica gel (95:5
CH2Cl2/MeOH) to give 15 (38 mg, 99%) as a white solid: Rf
0.25 (9:1 CH2Cl2/MeOH), mp 211 °C, [R]D +77.6 (c 1, CH2Cl2);
1H NMR (250 MHz, CDCl3) δ 2.57-2.80 (m, 4H), 2.91-3.05
(m, 2H), 3.14 (dd, J ) 8.3, 9.5 Hz, 2H), 3.39 (s, 6H), 3.45 (s,
6H), 4.48-4.76 (m, 6H), 4.10-4.23 (m, 2H), 4.40-4.51 (m, 2H),
4.672 (d, J ) 6.8 Hz, 2H), 4.674 (d, J ) 6.8 Hz, 2H), 4.79 (d,
J ) 6.8 Hz, 2H), 4.87 (d, J ) 6.8 Hz, 2H), 6.90-7.00 (m, 2H);
13C NMR (62.9 MHz, CDCl3) δ 31.7, 40.7, 56.0, 56.3, 70.2, 71.6,
72.1, 77.7, 81.4, 97.7, 98.0, 171.0. MS (MALDI): m/z 605.2 [M
+ Na]+.
EtOAc/CH2Cl2 then 9:1 CH2Cl2/MeOH) to give 2 (72 mg, 35%)
as a white solid: Rf 0.45 (9:1 CH2Cl2/MeOH), mp 226 °C, [R]D
1
+63.8 (c 1, CH2Cl2); H NMR (250 MHz, CDCl3) δ 2.57 (dd, J
) 15.4, 4.3 Hz, 3H), 2.68 (dd, J ) 15.4, 9.6 Hz, 3H), 3.32 (s,
9H), 3.35 (s, 9H), 3.36-3.49 (m, 6H), 3.64 (t, J ) 6.3 Hz, 3H),
3.70 (dd, J ) 4.0, 6.3 Hz, 3H), 3.78-3.88 (m, 6H), 4.47 (ddd, J
) 4.0, 4.3, 9.6 Hz, 3H), 4.58 (d, J ) 6.8 Hz, 3H), 4.63 (d, J )
11.4 Hz, 3H), 4.68 (d, J ) 6.8 Hz, 3H), 4.72 (d, J ) 6.5 Hz,
3H), 4.73 (d, J ) 11.4 Hz, 3H), 4.75 (d, J ) 6.5 Hz, 3H), 6.99-
7.09 (m, 3H), 7.21-7.40 (m, 15H); 13C NMR (62.9 MHz, CDCl3)
δ 35.1, 39.2, 56.0, 56.2, 69.2, 72.4, 74.1, 74.8, 75.7, 78.5, 97.2,
97.3, 127.90, 127.94, 128.5, 137.9, 170.8. MS(MALDI): m/z
1166.9 [M + Na]+.
Synthesis of Tetramer 20. Compound 18 (383 mg, 0.467
mmol) and compound 14 (395 mg, 0.490 mmol) were coupled
using general method C and purified over silica gel (9:1 CH2-
Cl2/MeOH) to give 20 (739 mg, 100%) as a white solid: Rf 0.11
(9:1 CH2Cl2/MeOH), mp 171 °C, [R]D +56.9 (c 1.35, CH2Cl2);
1H NMR (250 MHz, CDCl3) δ 2.32-2.94 (m, 8H), 3.21-3.92
(m, 52 H), 4.33-4.85 (m, 27H), 6.74-6.91 (m, 1H), 7.13-7.42
(m, 22H); 13C NMR (62.9 MHz, CDCl3) δ 32.1, 33.4, 33.8, 35.0,
38.69, 38.72, 38.8, 40.1, 51.3, 51.9, 55.90, 55.92, 55.93, 56.03,
56.04, 56.08, 56.11, 56.19, 59.61, 67.99, 71.09, 71.45, 71.83,
72.07, 72.55, 72.61, 72.65, 72.66, 73.60, 73.72, 73.87, 76.09,
76.12, 76.29, 76.41, 77.24, 79.83, 80.66, 96.57, 96.67, 96.70,
96.85, 96.88, 97.01, 97.55, 97.82, 97.99, 127.61, 127.69, 127.71,
127.78, 127.79, 127.87, 127.97, 128.37, 128.42, 128.46, 128.47,
128.51, 137.60, 137.66, 137.85, 137.91, 138.27, 170.23, 170.62,
170.93, 172.47. MS (MALDI): m/z 1606.1 [M + Na]+.
Synthesis of Cyclic Dimer 16. Compound 1 (50 mg, 0.066
mmol) was deprotected using general method G to give 16 (38
mg, 98%) as a pale yellow solid: Rf 0.64 (1:1 acetone/MeOH),
1
mp 131 °C (decomp), [R]D +73.5 (c 1, MeOH); H NMR (250
MHz, CD3OD) δ 2.54 (dd, J ) 15.6, 2.7 Hz, 2H), 2.72 (dd, J )
15.6, 12.2 Hz, 2H), 3.24-3.38 (m, 4H), 3.44 (t, J ) 8.5 Hz,
2H), 3.55-3.73 (m, 4H), 3.76 (dd, J ) 5.7, 8.7 Hz, 2H), 4.34
(ddd, J ) 2.7, 12.2, 5.7 Hz, 2H), 4.85 (s, 4H), 7.21-7.37 (m,
6H), 7.38-7.47 (m, 4H); 13C NMR (62.9 MHz, CD3OD) δ 33.2,
42.1, 71.8, 73.5, 73.7, 74.2, 75.8, 82.7, 128.5, 129.1, 129.2, 140.3,
173.4. MS (MALDI): m/z 609.3 [M + Na]+.
Synthesis of Cyclic Tetramer 3. Compound 20 (364 mg,
0.230 mmol) was saponified (method F), reduced (method B),
then cyclized (method E), and purified over silica gel (1:1
EtOAc/CH2Cl2 then 9:1 CH2Cl2/MeOH) to give 3 (218 mg, 62%)
as a white solid: Rf 0.13 (95:5 CH2Cl2/MeOH), mp 183 °C, [R]D
Synthesis of Cyclic Dimer 17. Compound 16 (20 mg,
0.034 mmol) was deprotected using general method F and
purified by precipitation in a MeOH/acetone mixture and
centrifugation (2×), giving 17 (10 mg, 74%) as a pale yellow
solid: Rf 0.35 (1:1 acetone/MeOH), mp 192 °C, [R]D +57.3 (c
1
+57.0 (c 1, CH2Cl2); H NMR (250 MHz, CDCl3) δ 2.51 (dd, J
) 15.4, 1.8 Hz, 4H), 2.79 (dd, J ) 15.4, 11.7 Hz, 4H), 3.14-
3.32 (m, 4H), 3.33 (s, 12H), 3.34 (s, 12H), 3.36-3.44 (m, 4H),
3.64 (t, J ) 7.1 Hz, 4H), 3.75 (dd, J ) 4.6, 7.1 Hz, 4H), 3.79-
3.92 (m, 4H), 3.93-4.09 (m, 4H), 4.50-4.85 (m, 28H), 6.87-
7.03 (m, 4H), 7.19-7.40 (m, 20H); 13C NMR (62.9 MHz, CDCl3)
δ 33.9, 40.3, 56.1, 56.3, 69.9, 71.3, 74.2, 76.0, 76.4, 79.0, 97.0,
97.3, 127.7, 127.8, 128.5, 138.1, 170.9. MS (MALDI): m/z
1547.9 [M + Na]+.
1
0.7, MeOH); H NMR (250 MHz, D2O) δ 2.54 (dd, J ) 15.5,
3.1 Hz, 2H), 2.72 (dd, J ) 15.5, 12.4 Hz, 2H), 3.19 (t, J ) 9.1
Hz, 2H), 3.36-3.64 (m, 8H), 3.72 (dd, J ) 6.1, 10.2 Hz, 2H),
4.36 (ddd, J ) 3.1, 12.4, 6.1 Hz, 2H); 13C NMR (62.9 MHz,
D2O) δ 32.3, 41.4, 70.8, 70.6, 72.9, 73.3, 73.7, 174.2. MS
(MALDI): m/z 429.1 [M + Na]+.
Synthesis of Amino Ester 18. Azido ester 13 (1.28 g, 1.56
mmol) was reduced using general method A to give 18 (1.02
g, 82%) as a white solid: Rf 0.33 (9:1 CH2Cl2/MeOH), mp 200
°C, [R]D +68.0 (c 1, CH2Cl2); 1H NMR (250 MHz, CDCl3) δ 1.86
(s, 2H), 2.55 (dd, J ) 15.4, 3.4 Hz, 1H), 2.60 (dd, J ) 16.1, 3.7
Hz, 1H), 2.69 (dd, J ) 15.4, 10.6 Hz, 1H), 2.82 (dd, J ) 16.1,
10.3 Hz, 1H), 2.85-3.01 (m, 2H), 3.33 (s, 3H), 3.34 (s, 3H),
3.35 (s, 3H), 3.36 (s, 3H), 3.39-3.49 (m, 3H), 3.71 (s, 3H), 3.56-
3.80 (m, 7H), 4.42-4.57 (m, 2H), 3.55-3.86 (m, 12H), 6.91-
7.04 (m, 1H), 7.27-7.37 (m, 10H); 13C NMR (62.9 MHz, CDCl3)
δ 33.7, 34.3, 39.0, 42.4, 52.1, 56.2, 56.3, 68.4, 70.6, 74.1, 74.7,
72.9, 73.6, 74.0, 75.5, 75.7, 76.6, 77.8, 80.1, 97.0, 97.7, 127.9,
128.0, 128.6, 137.8, 138.2, 170.7, 172.5. MS (MALDI): m/z
795.6 [M + H]+, 817.6 [M + Na]+.
Synthesis of Trimer 19. Compound 18 (642 mg, 0.809
mmol) and compound 10 (344 mg, 0.809 mmol) were coupled
using general method C and purified over silica gel (8:2 EtOAc/
cyclohexane) to give 19 (514 mg, 53%) as a white solid: Rf 0.35
(8:2 EtOAc/cyclohexane), mp 131 °C, [R]D +57.8 (c 1, CH2Cl2);
1H NMR (250 MHz, CDCl3) δ 2.40-2.95 (m, 6H), 3.13-3.97
(m, 40 H), 4.35-4.91 (m, 20H), 6.75-6.89 (m, 1H, NH), 7.09-
7.39 (m, 16H); 13C NMR (62.9 MHz, CDCl3) δ 33.6, 34.0, 35.3,
38.6, 38.8, 51.4, 52.0, 56.0, 56.1, 56.2, 56.3, 67.8, 67.9, 71.5,
71.9, 72.8, 72.9, 73.4, 73.7, 73.8, 74.0, 74.8, 75.2, 76.1, 76.4,
77.3, 80.6, 96.7, 96.9, 97.0, 97.9, 127.67, 127.71, 127.80, 127.83,
127.9, 128.0, 128.4, 128.5, 137.7, 137.8, 138.3, 170.2, 170.8,
172.5. MS (MALDI): m/z 1224.8 [M + Na]+.
Synthesis of Cyclic Tetramer 21. Compound 3 (20 mg,
0.013 mmol) was debenzylated using the general method F
and purified over silica gel (95:5 CH2Cl2/MeOH) to give 21 (9
mg, 59%) as a white solid: Rf 0.31 (9:1 CH2Cl2/MeOH), mp
120 °C, [R]D +51.2 (c 0.6, CH2Cl2); 1H NMR (250 MHz, CDCl3)
δ 2.52 (dd, J ) 15.3, 2.9 Hz, 4H), 2.67 (dd, J ) 15.3, 12.2 Hz,
4H), 2.89-3.04 (m, 4H), 3.19 (t, J ) 8.9 Hz, 4H), 3.42 (s, 12H),
3.46 (s, 12H), 3.65 (dd, J ) 5.8, 8.9 Hz, 4H), 3.69-3.81 (m,
4H), 3.83 (t, J ) 8.9 Hz, 4H), 3.91-4.04 (m, 4H), 4.42-4.56
(m, 4H), 4.68 (d, J ) 6.8 Hz, 4H), 4.71 (d, J ) 6.8 Hz, 4H),
4.80 (d, J ) 6.8 Hz, 4H), 4.83 (d, J ) 6.8 Hz, 4H), 6.93-7.06
(m, 4H); 13C NMR (62.9 MHz, CDCl3) δ 32.4, 41.6, 56.0, 56.3,
69.8, 71.3, 72.1, 78.0, 81.9, 97.4, 98.2, 170.9. MS (MALDI): m/z
1187.6 [M + Na]+.
Synthesis of Cyclic Dimer 4. BH3‚THF (1.5 M in THF,
1.05 mL, 1.572 mmol) was added to a solution of compound 1
(40 mg, 0.0525 mmol) in distilled THF (4 mL), and the mixture
was heated at 66 °C overnight. A few drops of EtOH were
added after cooling the solution, then the solvent was removed,
and the residue diluted in EtOH (4 mL) and refluxed for 48 h.
After evaporation, the residue was partitioned in a CH2Cl2/
NaOH (1 M in H2O) mixture. The aqueous layer was extracted
with CH2Cl2 (2×), and the combined organic layers were dried
(MgSO4) and evaporated to give 4 (35 mg, 91%) as a colorless
oil: Rf 0.26 (95:5:1 CH2Cl2/MeOH/Et3N), [R]D +60.1 (c 0.1, CH2-
1
Cl2); H NMR (250 MHz, CDCl3) δ 1.77-1.84 (m, 2H), 2.01-
Synthesis of Cyclic Trimer 2. Compound 19 (216 mg,
0.180 mmol) was saponified (method F), reduced (method B),
then cyclized (method E), and purified over silica gel (1:1
2.27 (m, 2H), 2.56-5.82 (m, 4H), 2.98-3.19 (m, 4H), 3.25 (t, J
) 8.2 Hz, 2H), 3.32 (s, 6H), 3.35 (s, 6H), 3.58-3.73 (m, 4H),
3.84-4.02 (m, 2H), 4.07-4.22 (m, 2H), 4.58 (d, J ) 6.8 Hz,
J. Org. Chem, Vol. 70, No. 11, 2005 4429